Français

For Universal Life Investment Accounts

CI Global Health Sciences Corporate Class A

Sector Equity

As Of: Nov 30, 2019

Fund Objective

This fund's objective is to obtain maximum long-term capital growth. It invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry. This includes companies that provide goods and services to these companies and companies that the portfolio advisor believes would benefit from developments in the health sciences industry.

Asset Allocation

Asset Percent
US Equity 62.48%
International Equity 34.13%
Cash and Equivalents 1.91%
Canadian Equity 1.48%

Sector Allocation

Sector Percent
Healthcare 84.53%
Consumer Services 7.97%
Financial Services 3.59%
Real Estate 2.00%
Cash and Cash Equivalent 1.91%

Geo Allocation

Region Percent
North America 65.87%
Europe 18.35%
Asia 14.61%
Latin America 1.17%

Top Holdings

Name Percent
Intercept Pharmaceuticals Inc 7.82%
SeaSpine Holdings Corp 5.77%
Takeda Pharmaceutical Co Ltd 5.40%
Bristol-Myers Squibb Co 5.35%
CVS Health Corp 5.23%
Biogen Idec Inc 5.21%
Alexion Pharmaceuticals Inc 5.15%
Astellas Pharma Inc 5.10%
GlaxoSmithKline PLC 3.94%
Ionis Pharmaceuticals Inc 3.60%

Category

Sector Equity

General Info

Inception Date Jul 23, 1996
MER 2.38%
Total Assets
(in millions)
$176.42

UL Fees

Wave 33 or later
Life Dimensions (Low Fees) 1.00%
Life Dimensions 2.25%
Wealth Dimensions 1.00%
Wave 32 or earlier (2016 or earlier)
Life Dimensions 2.75%
Life Dimensions (Low Fees) 1.50%
UL Investment Loan Plan 2.75%
Ultimate Dimension 1.25%

Fund Management Company

CI Investments Inc

Investment Style

Large
Value
Large
Blend
Large
Growth
Mid
Value
Mid
Blend
Mid
Growth
Small
Value
Small
Blend
Small
Growth
;

Fund Growth

Growth Summary

Investment Value $66,047.17
Rate of Return +560.47%
Values over period specified.

Legend

CI Global Health Sciences Corporate Class A

S&P/TSX Composite Index TR


Performance

1 Mth 3 Mth 6 Mth YTD 1 Yr 3 Yr 5 Yr 10 Yr Inception
Fund 11.0 15.0 6.8 8.9 -1.7 5.5 2.1 11.6 8.4
S&P/TSX Composite Index TR 3.6 4.4 7.9 22.3 15.7 7.3 6.1 7.2 -
Quartile - - - - - - - - -

Calendar Performance

2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Fund 1.1 6.4 -19.1 14.1 19.6 61.8 30.4 0.8 4.5 28.3
S&P/TSX Composite Index TR -8.9 9.1 21.1 -8.3 10.6 13.0 7.2 -8.7 17.6 35.1
Quartile - - - - - - - - - -

Volatility

Volatility: 10

Risk vs. Return

CI Global Health Sciences Corporate Class A

Median

Other - Sector Equity

Risk & Tax Efficiency

3 Yr 5 Yr 10 Yr
Standard Deviation 15.16 17.35 15.50
Beta 0.89 0.84 0.59
Alpha 0.00 -0.02 0.08
R-Squared 0.29 0.18 0.13
Sharpe Ratio 0.35 0.15 0.73
Sortino Ratio 0.23 -0.03 0.80
Treynor 0.06 0.03 0.19
Tax Efficiency 86.69 52.92 91.85

Category

Sector Equity

General Info

Inception Date Jul 23, 1996
MER 2.38%
Total Assets
(in millions)
$176.42

UL Fees

Wave 33 or later
Life Dimensions (Low Fees) 1.00%
Life Dimensions 2.25%
Wealth Dimensions 1.00%
Wave 32 or earlier (2016 or earlier)
Life Dimensions 2.75%
Life Dimensions (Low Fees) 1.50%
UL Investment Loan Plan 2.75%
Ultimate Dimension 1.25%

Fund Management Company

CI Investments Inc

Investment Style

Large
Value
Large
Blend
Large
Growth
Mid
Value
Mid
Blend
Mid
Growth
Small
Value
Small
Blend
Small
Growth